Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Methuen, Massachusetts 25 trials found
New Search
Filter
Trial Phase
Study Type
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Exercise in Metastatic Breast Cancer: EMBody
NAINTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
ETHAN - ET for Male BC
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NAINTERVENTIONAL Boston, Massachusetts +3 more
RECRUITING
CONFIRM: Magnetic Resonance Guided Radiation Therapy
NAINTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
PHASE1INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
VS-6766+Abema+Fulv in Met HR+/HER- BC
PHASE1, PHASE2INTERVENTIONAL Boston, Massachusetts +2 more
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
PHASE3INTERVENTIONAL Greenbrae, California +4 more
RECRUITING
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
PHASE1INTERVENTIONAL Chicago, Illinois +4 more
RECRUITING
Video Education With Result Dependent dIsclosure
NAINTERVENTIONAL Boston, Massachusetts
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
Screening For BCRL In Targeted Therapy For Breast Cancer
N/AOBSERVATIONAL Boston, Massachusetts
RECRUITING
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
PHASE1INTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NAINTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Boston, Massachusetts +3 more
RECRUITING
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
PHASE1INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
IKS014 in Advanced Solid Tumors That Express HER2
PHASE1INTERVENTIONAL Newport Beach, California +4 more
RECRUITING
Scalp Cooling in MBC
PHASE2INTERVENTIONAL Boston, Massachusetts +1 more
RECRUITING
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type